Key Takeaways
- PATH shares started trading at $16.24, declining from the previous close of $18.22, and dropped further to approximately $15.66 following the earnings announcement
- Second-quarter revenue reached $410.3 million, representing a 13.3% year-over-year increase and surpassing analyst expectations of $397.8 million
- Billings came in below projections at $375.5 million, with growth rates falling short when compared to other AI-focused software companies
- The company increased its fiscal 2027 revenue projection to a range of $1.789-$1.794 billion
- Wall Street maintains a collective “Hold” stance with an average price target of $15.73; meanwhile, CEO Daniel Dines divested more than $22 million worth of shares in August
Shares of UiPath (PATH) plummeted more than 16% on September 4 following the release of second-quarter fiscal 2027 results that, while exceeding revenue projections, fell short of satisfying investor expectations for AI-related technology stocks.
Trading commenced at $16.24, representing a significant decrease from the previous session’s closing price of $18.22, with shares ultimately settling around $15.12. This positions PATH approximately 21.6% beneath its 52-week peak of $19.29, which was reached in December 2025.
Quarterly revenue totaled $410.3 million, marking a 13.3% year-over-year expansion and exceeding the Street consensus forecast of $397.8 million. The company’s non-GAAP earnings per share of $0.15 aligned precisely with analyst predictions.
However, billings registered at $375.5 million, falling marginally below expectations. Company leadership attributed this shortfall to extended customer deliberation periods as organizations evaluate conventional automation solutions against emerging AI-powered alternatives.
Chief Executive Daniel Dines emphasized that 18 of the company’s 20 largest transactions during the quarter incorporated AI components, positioning UiPath as a beneficiary of enterprise AI transformation rather than a casualty. Despite this narrative, market participants remained unconvinced.
Expansion Rate Underwhelms in AI-Driven Market
Annual recurring revenue expanded 12% to $1.938 billion, and UiPath delivered its fourth consecutive quarter of GAAP profitability. Management also elevated its full-year revenue forecast to $1.789-$1.794 billion and projected approximately $445 million in non-GAAP operating income.
Third-quarter guidance ranging from $440 million to $445 million marginally exceeded analyst estimates, yet investors had anticipated more substantial projections after the stock’s approximately 9% advance just over a week prior.
The fundamental issue is clear: growth in the 12-13% range appears underwhelming when juxtaposed with rapidly expanding AI software competitors, while uncertainty persists regarding whether artificial intelligence will ultimately erode demand for conventional automation platforms.
Newly appointed CFO Hitesh Ramani addressed these concerns, stating that UiPath is adopting a “prudent approach” to forecasting given macroeconomic uncertainty and evolving customer implementation patterns.
Wall Street Maintains Cautious Stance
Analyst responses were restrained. BMO Capital Markets elevated its price objective from $13 to $18 while maintaining a Market Perform designation. Wells Fargo adjusted its target from $13 to $15 with an Equal Weight rating. Royal Bank of Canada shifted from $15 to $17 at Sector Perform. DA Davidson increased its target from $12 to $16 at Neutral, and TD Cowen moved from $13 to $16 at Hold.
Among 19 analysts tracking the company, 16 assign it a Hold rating, two recommend Buy, and one suggests Sell. The consensus price objective stands at $15.73.
Contributing to the reserved sentiment, CEO Daniel Dines liquidated 1.4 million shares on August 19 at an average price of $16.07, generating proceeds exceeding $22.5 million. His remaining stake comprises over 26 million shares.
Institutional stakeholders including State Street, Morgan Stanley, and AQR Capital have all expanded their holdings in recent quarters. Institutional ownership now represents 62.5% of outstanding shares.
PATH has declined 4.8% year to date, and investors who purchased $1,000 of the stock five years ago would currently hold approximately $242 in value.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
